Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: A randomized, multicenter, double-blind trial

Journal of Clinical Oncology

Volumn 18, Issue 6, 2000, Pages 1269-1278

  Henrickson, Kelly J ^a   Axtell, Richard A ^a   Hoover, Susan M ^a   Kuhn, Suzanne M ^a   Pritchett, Jodi ^a   Kehl, Sue C ^a   Klein, John P ^a  

^a HELEN DEVOS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; HEPARIN; VANCOMYCIN;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERICIDAL ACTIVITY; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENTEROCOCCUS; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; THROMBOSIS; VASCULAR ACCESS;

EID: 0034019108     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.6.1269     Document Type: Article

References (53)

1. Flynn PM: Vascular access device infections, in Patrick CC (ed): Infections in Immunocompromised Infants and Children. New York, NY, Churchill Livingstone, 1992, pp 289-298
2. Raad II, Bodey GP: Infectious complications of indwelling vascular catheters. Clin Infect Dis 15:197-210, 1992
3. Garner JS, Jarvis WR, Emori TG, et al: CDC definitions for nosocomial infections, 1988. Am J Infect Control 16:128-140, 1988
4. Mirro J, Rao BN, Stokes DC, et al: A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients. J Clin Oncol 7:214-222, 1989
5. Ingram J, Weitzman S, Greenberg ML, et al: Complications of indwelling venous access lines in the pediatric hematology patient: A prospective comparison of external venous catheters and subcutaneous ports. Am J Pediatr Hematol Oncol 13:130-136, 1991
6. Darbyshire PJ, Weightman NC, Speller DCE: Problems associated with indwelling central venous catheters. Arch Dis Child 60:129-134, 1985
7. Viscoli C, Garaventa A, Boni L, et al: Role of broviac catheters in infections in children with cancer. Pediatr Infect Dis J 7:556-650, 1988
8. Johnson PR, Decker MD, Edwards KM, et al: Frequency of broviac catheter infections in pediatric oncology patients. J Infect Dis 154:570-578, 1986
9. Donowitz LG, Haley CE, Gregory WW, et al: Neonatal intensive care unit bacteremia: Emergence of Gram-positive bacteria as major pathgens. Am J Infect Control 15:141-147, 1987
10. Decker MD, Edwards KM: Central venous catheter infections. Pediatr Clin North Am 35:579-612, 1988
11. Prince A, Heller B, Levy J, et al: Management of fever in patients with central vein catheters. Pediatr Infect Dis 5:20-24, 1986
12. King DR, Komer M, Hoffman J, et al: Broviac catheter sepsis: The natural history of an iatrogenic infection. J Pediatr Surg 20:728-733, 1985
13. Gorelick MH, Owen WC, Seibel NL, et al: Lack of association between neutropenia and the incidence of bacteremia associated with indwelling catheter venous catheters in febrile pediatric cancer patients. Pediatr Infect Dis J 10:506-510, 1991
14. Schwartz C, Henrickson KJ, Roghmann K, et al: Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol 8:1591-1597, 1990
15. Cairo MS, Spooner S, Sowden L, et al: Long-term use of indwelling multipurpose silastic catheters in pediatric cancer patients treated with aggressive chemotherapy. J Clin Oncol 4:784-788, 1986
16. Shapiro ED, Wald ER, Nelson KA, et al: Broviac catheter-related bacteremia in oncology patients. Am J Dis Child 136:679-681, 1982
17. Barriga FJ, Varas M, Potin M, et al: Efficacy of a vancomycin solution to prevent bacteremia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients. Med Pediatr Oncol 28:196-200, 1997
18. Henrickson KJ, Powell KR, Schwartz CL: A dilute solution of vancomycin and heparin retains antibacterial and anticoagulant activities. J Infect Dis 157:600-601, 1988 (letter)
19. Henrickson KJ, Dunne WM: Modification of a central venous catheter flush solution improves in vitro antimicrobial activity. J Infect Dis 166:944-946, 1992
20. Krol GJ, Benham BT: HPLC analysis of ciprofloxacin and ciprofloxacin metabolites in body fluids. J Pharm Biomed Anal 14:181-190, 1995
21. Pittet D, Tarara D, Wenzel RP: Nosocomial bloodstream infection in critically ill patients: Excess length of stay, extra costs, and attributable mortality. JAMA 271:1598-1601, 1994
22. Conly JM, Grieves K, Peters B: A prospective, randomized study comparing transparent and dry gauze dressings for central venous catheters. J Infect Dis 159:310-319, 1989
23. Linder LE, Curelaru I, Gustavsson B, et al: Material thrombogenicity in central venous catheterization: A comparison between soft, antebrachial catheters of silicone elastomer and polyurethane. J Patenteral Enteral Nutr 8:399-406, 1984
24. Sheth NK, Franson TR, Rose HD, et al: Colonization of bacteria on polyvinyl chloride and Teflon intravascular catheters in hospitalized patients. J Clin Microbiol 18:1061-1063, 1983
25. Rotrosen D, Calderone RA, Edwards JE: Adherence of Candida species to host tissues and plastic surfaces. Rev Infect Dis 8:73-85, 1986
26. Maki DG, Band JD: A comparative study of polyantibiotic and iodophor ointments in prevention of vascular catheter-related infection. Am J Med 70:739-744, 1981
27. Maki DG, Ringer M, Alvarado CJ: Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 338:339-343, 1991
28. Kingston D, Seal DV: Self-disinfecting plastics for intravenous catheters and prosthetic inserts. J Hyg Camb 96:185-198, 1986
29. Kamal GD, Pfaller MA, Rempe LE, et al: Reduced intravascular catheter infection by antibiotic bonding. JAMA 265:2364-2368, 1991
30. Maki DG, Wheller SJ, Stolz SM, et al: Clinical trial of a novel antiseptic central venous catheter. Program and Abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, American Society for Microbiology, 1991 (abstr461)
31. Mermel L, Stolz S, Maki D, et al: Antimicrobial activity of intravascular catheters. Pediatrie Research Program Issue. Baltimore, MD, American Academy of Pediatrics/American Society of Clinical Investigators/American Federation of Clinical Research Annual Meeting, 1992 (abstr A114)
32. Maki DG, Cobb L, Garman JK, et al: An attachable silver-impregnated cuff for prevention of infection with central venous catheters: A prospective randomized multicenter trial. Am J Med 85:307-314, 1988
33. Flowers RH, Schwenzer KJ, Kopel RF, et al: Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. JAMA 261:878-883, 1989
34. Heard SO, Wagle M, Vijayakumar E, et al: Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadizine on the incidence of cather-related bacteremia. Arch Intern Med 158:81-87, 1998
35. Maki DG, Stolz SM, Wheeler S, et al: Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnanted catheter: A randomized, controlled trial. Ann Intern Med 127:257-266, 1997
36. Raad I, Darouiche R, Dupuis J, et al: Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: A randomized, double-blind trial. Ann Intern Med 127:267-274, 1997
37. Clementi E, Marie O, Arlet G, et al: Usefulness of an attachable silver impregnated cuff for prevention of catheter-related sepsis (CRS)? Program and Abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC, American Society for Microbiology, 1989 (abstr 460)
38. Groeger J, Lucas A, Brown A, et al: Silver-impregnated cuffs on Hickman catheters in cancer patients: A prospective randomized study of infectious morbidity. Programs and Abstracts of the 29th Interscience Conference on Antimicrobiol Agents and Chemotherapy. Washington, DC, American Society for Microbiology, 1989 (abstr 1079)
39. Bach A, Darby D, Bottiger B, et al: Retention of the antibiotic teicoplanin on a hydromer-coated central venous catheter to prevent bacterial colonization in postoperative surgical patients. Intensive Care Med 22:1066-1069, 1996
40. Rackoff WR, Weiman M, Jakobowski D, et al: A randomized, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children. J Pediatr 127:147-51, 1995
41. Powell KR: Correction: Heparin-vancomycin solution to prevent central venous catheter infections. J Infect Dis 127:1008-1009, 1995
42. Rubie H, Juricic M, Claeyssens, et al: Morbidity using subcutaneous ports and efficacy of vancomycin flushing in cancer. Arch Dis Child 72:325-329, 1995
43. Daghistani D, Horn M, Rodriguez Z, et al: Prevention of indwelling central venous catheter sepsis. Med Pediatr Oncol 26:405-408, 1996
44. Henrickson KJ, Shenep JL: Fulminating staphylococcus epidermidis bacteremia. South Med J 83:231-234, 1990
45. Bender JW, Hughes WT: Fatal Staphylococcus epidermidis sepsis following bone marrow transplantation. Johns Hopkins Med J 146:13-15, 1980
46. Yao JDC, Arkin CF, Karchmer AW: Vancomycin stability in heparin and total parenteral nutrition solutions: Novel approach to therapy of central venous catheter related infections. J Parenteral Enteral Nutr 16:268-274, 1992
47. Barg NL, Supena RB, Fekety R: Persistent staphylococcal bacteremia in an intravenous drug abuser. Antimicrob Agents Chemother 29:209-211, 1986
48. Christ W, Lehnert T, Ulbrich B: Specific toxicologic aspects of the quinolones. Rev Infect Dis 10:S141-S146, 1988
49. Lumbiganon P, Pengswaa K, Sookpranee T: Ciprofloxacin in neonates and its possible adverse effect on the teeth. Pediatr Infect Dis J 6:932-935, 1991
50. Stutman HR: Summary of a workshop on ciprofloxacin use in patients with cystic fibrosis. Pediatr Infect Dis J 6:932-935, 1987
51. Schaad UB, Wedgwood-Krucko J: Efficacy and safety of ciprofloxacin in pediatric patients with cystic fibrosis. Rev Infect Dis 11:S118, 1989 (abstr)
52. Schaad UB, Sander E, Wedgwood J, Schaffner, T: Morphologic studies for skeletal toxicity after prolonged ciprofloxacin therapy in two juvenile cystic fibrosis patients. Pediatr Infect Dis J 11:1047-1049, 1992
53. Schaad UB: Role of the new quinolones in pediatric practice. Pediatr Infect Dis J 11:1043-1046, 1992